- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01606930
A Pilot Study to Improve Patient-Doctor Communication
The purpose of this controlled pilot study is to determine whether an intervention aimed at patients will improve partnering, shared decision-making and open communication. Results from this pilot study will inform how to best proceed with a larger multi-centered randomized controlled trial.
The specific hypothesis for this pilot study is to:
- Test the feasibility of a simple patient-centered intervention.
- Test the correlation between patient readiness to actively engage in conversation (assessed using a pre-visit patient survey) and actual patient behaviors in the encounter.
- Develop a coding tool that will quantify patient activation in clinical encounters.
- Test whether activating patients who are more involved and revealing in the patient-clinician dyad will improve patient and clinician outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Chronic illness requires a greater participation by the patient in the management of their own disease process. Patients now increasingly find themselves dealing with multiple illnesses over the span of their lifetime.
Patient-provider communication is key to optimal patient outcomes. Numerous studies have shown adverse effects of poor communication on a number of outcomes, including patient and provider satisfaction as well as medical compliance and health related outcomes.
An important next step in this field is to study whether it is possible to improve chronic illness care in real world settings by improving the quality of patient-provider interaction through feasible interventions focused on efficient, motivational, and empathic communication, targeted at both patients and providers.
There is little information on the best patterns of communication in dealing with patients with multiple comorbidities. The investigators believe that an optimal healing relationship between these patients and their healthcare providers includes shared decision-making, partnering between patients and clinicians to foster health and healthy behaviors in an environment of trust, and effective open communication.
An important outcome for this pilot study is feasibility. The investigators intend to conduct a follow-up multi-centered trial; planning and budgeting for such a trial will require information gleaned from this study. What is the rate of accrual and how many patients can realistically be enrolled and followed within the current study personnel. What outcomes are sensitive to change and how much change can the investigators expect to see? Will this intervention effect change in patient behavior? This study will give us insight to allow us to build a right-sized project.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Bethesda, Maryland, United States, 20889
- Walter Reed National Medical Military Center (WRNMMC)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Military health care beneficiaries presenting for chronic medical care with their primary care clinician
- Over the age of 18
- At least 2 and no more than 10 visits with their primary care provider in the previous year
- Receiving pharmacological treatment for hypertension
- At least 2 of the following common chronic illnesses: hyperlipidemia, chronic obstructive pulmonary disease, asthma, congestive heart failure, chronic pain, ischemic heart disease, osteoarthritis, depression, back pain, chronic headaches, or diabetes
Exclusion Criteria:
- Over the age of 80
- Incapable of completing the questionnaires, either due to cognitive impairment or lack of English-literacy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual Care Group
Group will see their physician without receiving the "activation" instrument.
|
|
Active Comparator: "Activated" Group
Group will be given an "activation" instrument to complete before their appointment and instructed to refer to and use the instrument during their clinical encounter.
|
The instrument is completed before the scheduled appointment and is designed to prompt patients to reflect on their specific goals for the medical encounter, prioritize those goals, and to "Prime" them to engage in a discussion centered on their concerns and expectations.
In addition, participants will be encouraged to bring this form into their physician visit and use it to engage their clinician in a discussion about their health needs.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Degree of shared medical decision-making
Time Frame: Baseline
|
Assessed from transcribed audio-tapes of the doctor-patient encounter using Roter Interaction Analysis System (RIAS).
|
Baseline
|
Adherence to anti-hypertensive drug treatment at baseline
Time Frame: Baseline
|
This outcome will be assessed using pill counts by the pharmacists.
|
Baseline
|
Adherence to anti-hypertensive drug treatment at one month
Time Frame: One month
|
This outcome will be assessed using pill counts by the pharmacists.
|
One month
|
Adherence to anti-hypertensive drug treatment at three months
Time Frame: Three months
|
This outcome will be assessed using pill counts by the pharmacists.
|
Three months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient satisfaction
Time Frame: Baseline
|
Post-encounter survey using the validated Rand-9 Patient Satisfaction Tool
|
Baseline
|
Clinician rating of patient as "difficult"
Time Frame: Baseline
|
Clinician Rating of the Encounter Using the Difficult Doctor-Patient Relationship Questionaire (DDPRQ).
|
Baseline
|
Patient Trust in their physician at baseline
Time Frame: Baseline
|
Validated Trust in Physician (11-item) Instrument
|
Baseline
|
Patient Trust in their physician at one month
Time Frame: one month
|
Validated Trust in Physician (11-item) Instrument
|
one month
|
Patient Trust in their physician at three months
Time Frame: Three months
|
Validated Trust in Physician (11-item) Instrument
|
Three months
|
Systolic and Diastolic Blood Pressure at baseline
Time Frame: Baseline
|
Each blood pressure data point was the average of 3 measurements measured 5 minutes apart while seated.
|
Baseline
|
Systolic and Diastolic Blood Pressure at one month
Time Frame: One month
|
Each blood pressure data point was the average of 3 measurements measured 5 minutes apart while seated.
|
One month
|
Systolic and Diastolic Blood Pressure at three months
Time Frame: three months
|
Each blood pressure data point was the average of 3 measurements measured 5 minutes apart while seated.
|
three months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Patrick O'Malley, MD, MPH, Walter Reed National Military Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- A-14352.4
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
Clinical Trials on Patient Primer Tool
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingUrinary Incontinence | Overactive Bladder SyndromeUnited States
-
Region GävleborgUniversity of GavleNot yet recruitingWork Related Stress
-
Duke UniversityNational Institutes of Health (NIH)Not yet recruitingAtrial FibrillationUnited States
-
Bracane CompanyIFG MedicalTerminatedChronic Pain | Fungal InfectionUnited States
-
University of BaghdadRecruitingWhite Spot Lesion of ToothIraq
-
Bradford Teaching Hospitals NHS Foundation TrustUnknownBracket Failure Rate | Bonding Time Per Bracket | Adhesive Remnant Index for Type of Bond Failure | Length of Treatment | Peer Assessment Rating
-
Lawson Health Research InstituteCanadian Orthopaedic FoundationCompleted
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH); Massachusetts General Hospital; Beth...Enrolling by invitationHIV-infection/AIDSUnited States
-
VA Puget Sound Health Care SystemCompleted